Suppr超能文献

诱导型一氧化氮合酶(NOS2)基因敲除小鼠作为拔毛癖模型

Inducible nitric oxide synthase (NOS2) knockout mice as a model of trichotillomania.

作者信息

Casarotto Plinio C, Biojone Caroline, Montezuma Karina, Cunha Fernando Q, Joca Samia R L, Castren Eero, Guimaraes Francisco S

机构信息

Neuroscience Center, University of Helsinki, Helsinki, Finland.

Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.

出版信息

PeerJ. 2018 Apr 17;6:e4635. doi: 10.7717/peerj.4635. eCollection 2018.

Abstract

BACKGROUND

Trichotillomania (TTM) is an impulse control disorder characterized by repetitive hair pulling/trimming. Barbering behavior (BB) observed in laboratory animals is proposed as a model of TTM. The neurobiological basis of TTM is unclear, but involves striatal hyperactivity and hypoactivation of the prefrontal cortex.

METHODS

In this study, we evaluated the BB in knockout mice for the inducible isoform of nitric oxide synthase (NOS2KO) and the consequences of silencing this enzyme in PC12 cell differentiation.

RESULTS

NOS2KO exhibit exacerbated BB, starting four weeks of age, and increased repetitive movements compared to wild-type mice (WT). The expression of BB was attenuated by repeated treatment with clomipramine, a clinically approved drug to treat TTM in humans, or memantine, an antagonist of NMDA receptors, as well as partial rescue of NOS2 expression in haploinsufficient animals. The silencing of NOS2 expression reduced the MAP2 (microtubule-associated protein 2) levels in activity-induced differentiated PC12 cells.

DISCUSSION

Our data led us to propose that NOS2 is putatively involved in the neuronal maturation of the inhibitory afferent pathways during neurodevelopment, and such inadequate inhibition of motor programs might be associated to the observed phenotype.

摘要

背景

拔毛癖(TTM)是一种冲动控制障碍,其特征为反复拔毛/修剪毛发。在实验动物中观察到的理发行为(BB)被提议作为TTM的一种模型。TTM的神经生物学基础尚不清楚,但涉及纹状体活动亢进和前额叶皮质活动减退。

方法

在本研究中,我们评估了一氧化氮合酶诱导型同工型基因敲除小鼠(NOS2KO)的BB情况,以及在PC12细胞分化过程中沉默该酶的后果。

结果

与野生型小鼠(WT)相比,NOS2KO从4周龄开始出现加剧的BB,且重复动作增加。用氯米帕明(一种临床上批准用于治疗人类TTM的药物)或美金刚(一种NMDA受体拮抗剂)反复治疗可减轻BB的表现,同时在单倍剂量不足的动物中部分恢复NOS2的表达。沉默NOS2表达会降低活动诱导分化的PC12细胞中微管相关蛋白2(MAP2)的水平。

讨论

我们的数据使我们提出,NOS2可能在神经发育过程中参与抑制性传入通路的神经元成熟,而对运动程序的这种抑制不足可能与观察到的表型有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bdb/5909682/c26f2f9d7c1b/peerj-06-4635-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验